SCF FBXW11 Complex Targets Interleukin-17 Receptor A for Ubiquitin-Proteasome-Mediated Degradation.
Ben JinSayed Ala MoududeeDongxia GePengbo ZhouAlun R WangYao-Zhong LiuZongbing YouPublished in: Biomedicines (2024)
Interleukin-17 (IL-17) is a pro-inflammatory cytokine that participates in innate and adaptive immune responses and plays an important role in host defense, autoimmune diseases, tissue regeneration, metabolic regulation, and tumor progression. Post-translational modifications (PTMs) are crucial for protein function, stability, cellular localization, cellular transduction, and cell death. However, PTMs of IL-17 receptor A (IL-17RA) have not been investigated. Here, we show that human IL-17RA was targeted by F-box and WD repeat domain-containing 11 (FBXW11) for ubiquitination, followed by proteasome-mediated degradation. We used bioinformatics tools and biochemical techniques to determine that FBXW11 ubiquitinated IL-17RA through a lysine 27-linked polyubiquitin chain, targeting IL-17RA for proteasomal degradation. Domain 665-804 of IL-17RA was critical for interaction with FBXW11 and subsequent ubiquitination. Our study demonstrates that FBXW11 regulates IL-17 signaling pathways at the IL-17RA level.
Keyphrases
- rheumatoid arthritis
- immune response
- cell death
- disease activity
- stem cells
- ankylosing spondylitis
- systemic lupus erythematosus
- transcription factor
- oxidative stress
- cancer therapy
- toll like receptor
- binding protein
- epithelial mesenchymal transition
- systemic sclerosis
- high resolution
- interstitial lung disease
- inflammatory response
- single molecule
- amino acid